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Molecular characterization of neuron populations, particularly those controlling threat
responses, is essential for understanding the cellular basis of behaviour and identifying
pharmacological agents acting selectively on fear-controlling circuitry. Here we demonstrate a
comprehensive workﬂow for identiﬁcation of pharmacologically tractable markers of
behaviourally characterized cell populations. Thy1-eNpHR-, Thy1-Cre- and Thy1-eYFP-labelled
neurons of the BLA consistently act as fear inhibiting or ‘Fear-Off’ neurons during behaviour.
We use cell-type-speciﬁc optogenetics and chemogenetics (DREADDs) to modulate activity
in this population during behaviour to block or enhance fear extinction. Dissociated
Thy1-eYFP neurons are isolated using FACS. RNA sequencing identiﬁes genes strongly
upregulated in RNA of this population, including Ntsr2, Dkk3, Rspo2 and Wnt7a. Pharmaco-
logical manipulation of neurotensin receptor 2 conﬁrms behavioural effects observed in
optogenetic and chemogenetic experiments. These experiments identify and validate
Ntsr2-expressing neurons within the BLA, as a putative ‘Fear-Off’ population.
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O
verexpression of learned fear underlies many neuropsy-
chiatric disorders such as phobia, panic disorder and
post-traumatic stress disorder. Hallmark symptoms of
post-traumatic stress disorder such as re-experiencing memories
of traumatic events, intrusive thoughts and hyper-arousal are
likely precipitated by the over-consolidation of and failure to
extinguish learned fear associations1,2. Classical fear conditioning
allows for the controlled study of neuronal processes mediating
associative fear. Pavlovian fear conditioning is a learning
paradigm wherein an initially neutral conditioned stimulus
(CS; for example, a tone) is paired with an aversive
unconditioned stimulus (US; for example, a mild footshock).
After several CSþUS pairings, mice display threat responses
(also referred to as fear behaviours) upon presentation of the tone
CS alone, here, fear behaviours are measured by quantifying
freezing (when the mouse ceases all non-homeostatic motion)3.
During fear extinction, the CS tone is presented in the absence of
any US shock until the threat responses return to baseline3–6. The
amygdala is well known to have an essential role in most fear
behaviours, speciﬁcally in the acquisition and extinction of
learned associations7,8. Here we will refer to fear conditioning as
the training phase where CS/US associations are acquired, fear
extinction as the early period where CS presentations in the
absence of US lead to decrement in freezing, and fear extinction
retention as a later period where additional CS presentations
measure the strength of retention of initial extinction event and
act as additional extinction events. It should be noted that fear
expression, fear extinction and extinction retention are
overlapping processes, where we are measuring the balance of
signalling processes rather than unitary elements acting
independently, thus early fear extinction measures primarily
fear expression to CS and extinction, while late fear extinction
measures primarily extinction expression and consolidated
retention of previous extinction learning.
Essential to understanding the opposing processes of fear
acquisition and its extinction is the identiﬁcation of neuronal
circuits mediating each process9–13. Furthermore, development of
rationally designed pharmaceuticals that act directly on fear-
inhibiting circuitry depends on discovering the molecular
identities of neuronal populations that speciﬁcally mediate fear
extinction. Within the basolateral amygdala (BLA), two
electrophysiologically distinct populations of principal neurons
neurons have been described, one increasing ﬁring in response to
the CS to signal fear conditioning and expression (Fear-On) and
the other increasing its ﬁring to the CS during fear extinction
(Fear-Off); differences in the activity in these populations have
been shown to accurately predict freezing behaviour of mice10.
Identifying the molecular identities of these populations
represents a major step towards full characterization of this
circuit14. Importantly, we have previously electrophysiologically
and functionally described a population marked by the Thy1
expression cassette that contains elements of the Fear-Off
population15. Thy1-channelrhodopsin-2 (Thy1-ChR2-eYFP)
and Thy1-YFP lines mark a population of glutamatergic
pyramidal neurons within the BLA, with signiﬁcant speciﬁcity
for the anterior basal amygdala16. Optogenetic activation of this
population leads to the inhibition of a population of central
amygdala (CeA) neurons and shunts excitatory drive from the
lateral amygdala (LA). Behaviourally, brief activation of these
neurons co-terminating with an unreinforced CS during
extinction learning leads to enhanced extinction retention.
It is critical to further describe the behavioural and molecular
phenotypes of this important population of cells, and in doing so
identify a cell-type-speciﬁc pharmacological substrate for enhan-
cing fear inhibition. This work presents a work-ﬂow to achieve
this goal that may be applied to any genetically identiﬁed neuron
population. Additional Thy1 transgenic lines are further
functionally dissected with optogenetics and chemogenetics,
demonstrating the necessity of these neurons for fear extinction
learning. Furthermore, we characterize the RNA and protein
expression patterns of this population, and identify neurotensin
receptor 2 (NTSR2) as one of several possible pharmacologically
targetable markers of this fear-inhibiting neural circuitry. Our
data suggest that pharmacological modulation of NTSR2 activity
during behaviour recapitulates effects observed from manipula-
tion of Thy1 neurons, suggesting a consistent role for this neural
population in fear inhibition.
Results
Thy1 marks consistent population of BLA neurons. Expression
patterns were assessed across: Thy1-eYFP line-H (Fig. 1a)16,17,
Thy1-eNpHR line 2 (Fig. 1b)18,19, Thy1-ChR2-EYFP line 18
(Fig. 1c)20 and Thy1-Cre line 1 (Fig. 1d)21. All lines produce high
levels of transgene speciﬁcally within the BLA primarily the
anterior BLA, sparing the LA, CeA and more caudally the
basomedial amygdala. The Thy1-eYFP line was crossed with the
Thy1-Cre line and infused unilaterally into the BLA with a Cre-
dependent reporter virus. The resulting YFP ﬂuorescence from
the Thy1-eYFP line and mCherry from Thy1-Cre line exhibited
strong overlap. Of mCherry (Thy1-Cre) labelled cells in the
BLA, 93% were also YFP labelled demonstrating strong coherence
in the identity of this population marked across Thy1 lines
(Fig. 1g–i). Because the rate of infected neurons is likelyo100%,
it is not possible to positively verify the proportion of YFPþ
neurons that concurrently express Cre in this system; however,
these data suggest that the Thy1-Creþ population is contained
almost entirely within the Thy1-YFP population. The reporter
virus used here is extremely sensitive to recombination and may
be recombined by a single molecule of Cre thereby detecting
expression levels of Cre that are subthreshold for signiﬁcant
transgene expression in other lines (discussed in greater depth in
supplement). For similar reasons, when the Thy1-Cre mouse
line was crossed with reporter lines, as was done in initial
characterization, a much larger population of cortical neurons is
marked. Alternatively, this may suggest promiscuous expression
during development with a more constrained pattern at
adulthood; each possibility is discussed at greater length
in Supplementary Discussion21. Co-localization between
Thy1-eNpHR and other lines was not possible with this scheme
because the transgene product is membrane bound making
visualization of individual cell bodies within the densely
populated BLA very difﬁcult.
Separate neuron populations active during fear processes.
Thy1-ChR2-eYFP-expressing neurons of the BLA appear to
contain a ‘Fear-Off’ controlling population (Jasnow et al.15).
To verify that the Thy1-eYFP-marked population plays the same
role in behaviour, each of four cohorts of Thy1-eYFP mice
(home cage, fear conditioned, fear extinction and extinction
retention) was put through the classical auditory fear-
conditioning paradigm and sacriﬁced immediately following
selected session15. All tissue was processed and stained for
c-Fos expression using immunohistochemistry (Fig. 1e). Follo-
wing fear expression/extinction training, a signiﬁcant increase in
c-Fos was observed in the YFP but not the YFPþ population.
However, following the extinction retention test, a signiﬁcant
increase in c-Fos was observed in the YFPþ but not the YFP
population, suggesting that the BLA is involved in both fear
expression and extinction, but the Thy1 population is selectively
recruited during extinction and extinction retention. These data
agree with previous the data, suggesting that Thy1þ neurons
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may be crucial for the encoding of fear extinction; from this lens,
we would expect the Fear-On (Thy1-) population to be primarily
active during the early phases of fear extinction, while the Fear-
Off (Thy1þ ) population should increase activity as extinction
progresses, thus during extinction retention session (which is also
an additional extinction session) the YFPþ population is
primarily active, while the YFP population is less activated.
These behaviours do overlap during extinction and extinction
retention, thus a long extinction test was used, so that during the
extinction retention session the mouse is well within the
extinction expression phase and a preponderance of the c-fos
staining is observed in the Thy1þ population during this session.
Electrophysiological characterization of Thy1-eNpHR neurons.
To conﬁrm that eNpHR is capable of inhibiting Thy1 neurons, we
measured the electrophysiological properties and light response
of Thy1-eNpHR-eYFP neurons in BLA slice. As expected,
we found strong laser illumination (wave length 593 nm,
3.6–10mWmm 2) induced hyperpolarization of BLA principal
neurons(Fig. 2a). Laser illumination was sufﬁcient to inhibit
current injection-induced spiking in eNpHR-YFP-expressing
neurons (Fig. 2b). To conﬁrm that transgene expression has no
adverse effects on normal neuron ﬁring in response to extrinsic
inputs, normal action potential generation in eNpHR-expressing
neurons was measured with electrical stimulation of LA (Fig. 2c
upper). The action potential was effectively abolished with laser
illumination (Fig. 2c, lower). Trains of action potentials were
reliably produced by 10Hz electrical stimulation (Fig. 2d, upper).
These action potentials were effectively blocked by laser illumi-
nation (Fig. 2d, lower). Taken together these results demonstrate
that in the absence of laser light, eNpHR-eYFP-expressing
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Figure 1 | Thy1 lines mark BLA population that is active during expression of fear extinction. (a) Thy1-eYFP, (b) Thy1-eNpHR, (c) Thy1-ChR2, each have
strong expression enriched in the BLA. (d) Cre recombinase driven by the Thy1.2 cassette in the Thy1-cre mouse, when visualized via infusion of AAV- hSyn-
DIO-rM3D(Gs)-mCherry, marks the same regional population as marked by the Thy1-eYFP mouse. (e) Representative images of a ﬁeld of view analysed for
c-fos staining in the BLA of Thy1-YFP mouse after fear expression. Co-localization was manually scored at 40 magniﬁcation,  10 images are for reference.
Upper panels: YFPþ expression in BLA of examined Thy-1 YFP mice. Green neurons in upper panels are YFPþ neurons while black c-fosþ nuclei are
depicted in lower panels. Fields for analysis were chosen at random within strongly YFP expressing area. Fields of were visually inspected for co-labelling of
c-fos and YFP. Example neurons identiﬁed: arrowhead indicates c-fosþ /YFPþ cell, while asterisk indicates c-fosþ /YFP cell. (f) Quantiﬁcation of
co-labelling of YFP or non-YFP-marked cells with c-fos in Thy1-eYFP mouse. Counts represented as number of positive events per ﬁeld analysed. BLA sections
were analysed after (1) untrained home cage controls (HC), (2) fear conditioning (FC), (3) fear extinction (FE) or (4) fear extinction retention (FR). Thy1-
eYFPþ neurons are c-fosþ signiﬁcantly more often after fear extinction testing versus home cage, while eYFP-marked neurons stain for c-fos signiﬁcantly
more often during fear expression (two-way ANOVA, F(3,40) P¼0.0017, when signiﬁcant main or interaction effects were found by the ANOVAs, Sidak’s post
hoc tests were carried out to locate simple effects. Sidak’s multiple comparisons versus home cage: *Po0.05, *Po0.005, error bars indicate±s.e.m. Sidak’s
multiple comparison post hoc analysis: YFPþ HC versus YFP FE Po0.05, YFPþ FC versus YFP FE Po0.05, YFPþ FE versus YFP FE: Po0.05, YFP
HC versus YFP FE Po0.05, YFP FE versus YFP FR: Po0.05, error bars indicate mean±s.e.m.). (g–i) Infusion of AAV-EF1a-DIO mCherry into double
transgenic Thy1-eYFP/Thy1-Cre mouse allows co-localization of neurons marked by each transgene. Arrows indicate neurons with co-localization. Asterisks
indicate neuron marked only by mCherry. Scale bar, 100mm (a–d, e upper left and lower left); scale bar, 20mm for (g–i, e upper right and lower right).
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neurons have normal responses to synaptic input and laser light is
sufﬁcient to consistently hyperpolarize these neurons blocking the
majority of generated action potentials.
Optogenetic silencing of Thy1 neurons. Mice were implanted
with optical ﬁbres housed within ceramic ferrules unilaterally, just
dorsal to the amygdala, aimed at the BLA of Thy1-eNpHR
carrying and non-carrier controls. Fibre tip placement was
conﬁrmed using Cresyl violet staining and any mouse whose ﬁbre
was not placed over BLA was excluded from analysis
(Supplementary Fig. 1a). Mice were mildly fear conditioned to
avoid ceiling effects (5CSþUS, 0.4mA US foot shock). Yellow
(593 nm) light was tonically applied throughout the 30-s CS
(Fig. 3a). Inhibition of Thy1-eNpHR neurons during acquisition
caused no changes in within-session behaviour; however, during
15 CS fear extinction session (considered a partial/sub-optimal
extinction session) in the absence of yellow laser stimulation,
Thy1-eNpHR carriers expressed signiﬁcantly more freezing
throughout the session. These results suggest that during fear
acquisition, the BLA Thy1 population acts as a brake on fear
learning and when it is silenced, fear acquisition is enhanced.
Importantly, Thy1-eNpHR carriers and non-carriers that are
cannulated and trained in an identical manner, but never receive
any laser light, exhibit identical levels of freezing, conﬁrming
that any behavioural differences are caused by light-mediated
silencing (Supplementary Fig. 2).
To determine whether BLA Thy1 neurons play a role during
fear expression, a naive cohort of Thy1-eNpHR-expressing and
non-carrier littermates received optic ﬁbre implants, and was fear
conditioned without any laser application (Fig. 3b). During short
15 CS fear extinction, laser light was applied throughout the CS.
Thy1-eNpHR carriers expressed signiﬁcantly more fear through-
out the session starting from the ﬁrst tone, suggesting that
inhibition of BLA Thy1 neurons reversed inhibition of the fear
trace allowing for enhanced expression. Thy1-eNpHR carriers
displayed signiﬁcantly more freezing during 1 CS unstimulated
expression test, suggesting that previous inhibition had not only
enhanced fear expression, but blunted extinction as well. Mice
were further extinguished (retention) to 30 CS’s with laser
application during the CS. Thy1-eNpHR carriers expressed
enhanced fear throughout this fear extinction session. By the
end of the session both groups of mice extinguished to baseline
freezing levels. Finally, once a fearful association is extinguished,
the inhibition of BLA Thy1 neurons during the ﬁnal extinction
session is not sufﬁcient for the reinstatement and does not drive
spontaneous fear expression.
These changes in fear behaviour were not accompanied with
any anxiety or locomotor effects indicated by similar time spent
in the centre of an open ﬁeld (Fig. 3c) and distance travelled
(Fig. 3d) by both groups, regardless of whether laser light was on
or off. Placement of ﬁbre tip was conﬁrmed by Cresyl violet
staining (Supplementary Fig. 1b).
Chemogenetic activation of Thy1 neurons. The Thy1-Cre line
was utilized to modulate activity in Thy1 neurons using chemo-
genetics (Fig. 4a). Designer receptors exclusively activated by
designer drugs (DREADDs) are modiﬁed G-protein-coupled
receptors that are activated exclusively by an otherwise
inert ligand, clozapine-N-oxide (CNO)22–24. Here, we use a
Gs-coupled DREADD that is known to increase intracellular
cAMP levels and enhance excitability when CNO is bound25,26.
Thy1-Cre mice were infected bilaterally with either AAV-DIO-
Gs-DREADD-IRES-mCherry or AAV-CaMKII-eYFP. Expression
of Gs DREADD infection is isolated to BLA; however, the pan-
excitatory neuron expressing CaMKII-eYFP virus resulted in
strong reporter expression throughout the amygdala (Fig. 4b).
Mice were fear conditioned (0.65mA CS, 10CSþUS pairings).
The Friend virus type-B (FVB) background of the Thy1-Cre mice
is not a high-freezing line, thus a stronger fear-conditioning
paradigm (10CSþUS) was necessary to achieve sufﬁcient levels
of freezing for experimental manipulation. Mice were injected
with CNO twice at 1mg kg 1, once 30min before fear extinction
and again 24 h later before the extinction retention session26.
Mice expressing the Gs-DREADD expressed similar levels of fear
200 pA 3 s
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Figure 2 | Halorhodopsin inhibition of BLAThy-1 neurons. (a) Light activation of halorhodopsin (593 nm) induced membrane hyperpolarization in a Thy-1
neuron; strength of hyperpolarization is time and intensity-dependent. (b) Halorhodopsin activation abolished inward current injection-induced ﬁring;
(c) upper, electrical stimulation of lateral amygdala induced action potential in a BLA Thy-1 neuron; middle, light evoked membrane hyperpolarization in
Thy-1 neuron; bottom, the action potential was abolished by light illumination; arrowheads indicate stimulus artifact from LA stimulation. (d) Upper, a train
of action potentials induced by 10Hz electrical stimulation of LA, lower, the ﬁring was reduced by concurrent halorhodopsin activation. Delays in action
potential suppression are likely due to transient and complex dynamics of intrinsic ion channels during eNpHR facilitated hyperpolarization. Similar delays
were found in original characterizations of Thy1-NpHR mouse lines. For additional characterization of NpHR and eNpHR in Thy1 mouse lines, please see
refs 18,19.
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Figure 3 | In vivo inhibition of Thy1 neurons. Inhibition of Thy1 neurons enhances fear consolidation and fear expression, while blunting fear extinction
consolidation. BLA neurons of mice expressing halorhodopsin under the control of the Thy1.2 expression cassette were silenced during select phases of fear
conditioning to determine their precise role in behaviour. This change in fear behaviour was not caused my changes in anxiety-like behaviour. (a) Silencing
BLA Thy1 neurons during weak fear acquisition results in no signiﬁcant within-session changes in behavior; however, 24-h later mice carrying the Thy1-
halorhodopsin gene express signiﬁcantly more fear during fear extinction (two-way Repeated measures (RM) ANOVA, F(1,14)¼ 5.827 ,*Po0.05). (b) Mice
weakly fear conditioned in the absence of laser stimulation show no within-session behavioral differences; however, 24-h later when laser stimulation is
applied during CS-on period of extinction, mice carrying the Thy1-halorhodopsin gene express signiﬁcantly more fear (two-way RM ANOVA,
F(1,12)¼ 10.08,**Po0.01). Thy1-halorhodopsin carrying mice exhibit signiﬁcantly enhanced fear 24-h later in the absence of laser stimulation (Student’s t-
test, **Po0.01). 24-h later, enhanced freezing is measured throughout the extinction retention session when laser stimulation is provided during CS-on
period (two-way RM ANOVA, F(1,11)¼ 7.75, *Po0.05). 24-h later no difference in freezing to CS is detected in the absence of laser stimulation. A ﬁnal
extinction session with laser stimulation during CS presentation reveals no differences in freezing. (c) Inhibition of BLAThy 1 neurons was not accompanied
by any change in anxiety-like behavior or (d) ambulation. Thy1-halorhodopsin carriers spent the same amount of time in the centre of an open ﬁeld as
controls whether laser light was on or off. Thy1-halorhodopsin carriers travelled the same distance whether laser light was on or off. (e) Schematic of
optical ﬁbre placed dorsal to the BLA providing yellow laser illumination during experimental procedures. Light is estimated to maintain 410mW power
within 0.5mm of the ﬁbre optic tip. In all panels error bars indicate mean±s.e.m.
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to the tone during the initial 15 CS fear extinction test; however,
24 h later during a 30 CS extinction retention session they
expressed signiﬁcantly less fear (Fig. 4a).
These results suggest that tonic enhancement of excitability in
BLA Thy1 neurons during the extinction session is not sufﬁcient
for within-session changes in behaviour. However, enhanced
excitability is sufﬁcient to enhance the fear extinction consolida-
tion, resulting in overall marked decreases in fear expression
during the subsequent fear extinction retention session. However,
it is possible that CNO administered before extinction retention
enhances extinction expression, despite having no within-session
effect during extinction. Taken together these results further
support the hypothesis that the BLA Thy1 neurons are a ‘Fear-
Off’ population.
Isolation and molecular characterization of Thy1 neurons. We
next wished to further understand the molecular components that
differentiate the Thy1þ cells from the Thy1 cells, hypothe-
sizing that these cells may underlie genetic differences in the
Fear-On versus Fear-Off BLA populations. Furthermore, to
rationally identify pharmaceuticals that selectively modulate
known fear-controlling circuits, it is advantageous to know the
molecular expression proﬁles of targeted neurons. To approach
this problem, we isolated Thy1 neurons using ﬂuorescence-acti-
vated cell sorting (FACS), then interrogated their molecular
identity using RNA sequencing. To obtain puriﬁed samples of
Thy1-eYFP neurons, 1mm punches of tissue centred over BLA
were taken from Thy1-eYFP-expressing mice and pooled
(Fig. 5a). Tissue was dissociated into a single-cell suspension and
ﬁxed for staining with NeuN antibody and Hoechst; this allowed
identiﬁcation and isolation of speciﬁc neuronal cell bodies27–29.
Voltages and gates were set using wild-type C57/B6 stained and
unstained controls. Samples were analysed for forward scatter and
side scatter characteristics. A large portion of NeuN positive,
Hoechst positive events were found in a small population near the
bottom of the plot, so this population, corresponding to cell
bodies, was chosen for further interrogation (Fig. 5b, inset). We
collected two populations, one strongly NeuN positive, strongly
YFP negative and the other strongly NeuN positive, strongly YFP
positive (Fig. 5b). Although this method reduced the total yield, it
increased the purity of collected neurons. Overall, of all cell
bodies interrogated, 40% were NeuN positive, while only B2%
were NeuN and YFP double positive. Collected cells were
conﬁrmed to be either single or double positive using micro-
scopy. Following isolation, RNA was immediately collected from
samples and later sequenced.
RNA sequencing revealed thousands of differentially regulated
genes between Thy1-eYFP and other neurons. This list was then
curated based upon a set of criteria demanding the gene must be
highly signiﬁcant controlling for false discovery rate (qo0.05),
and differentially regulated at a fold change 420.5 (Supple-
mentary Fig. 3). Furthermore, a list of gene hits meeting these
inclusion criteria was input into the drug-able genome database
(DGIdb) and interaction partners were searched for from expert
curated lists, thus allowing for identiﬁcation of gene targets that
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Figure 4 | Enhancing excitability of BLA Thy1 neurons using DREADDs. Mice harbouring the Thy1-cre gene were infected with AAV-EF1a-DIO-
rM3D(Gs)-mCherry or control virus AAV-CamKII-eYFP. Mice were auditory fear conditioned then administered clozapine-N-oxide 30min before fear
extinction and fear extinction retention sessions. (a) Tonic enhancement of excitability of BLA Thy-1 neurons during fear extinction enhances consolidation
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or control virus is visualized using mCherry or YFP tag. Cre-dependent recombination causes expression of Gs-DREADD-mCherry to be isolated to BLA
Thy1 neurons, while control virus has widespread expression throughout amygdala. Scale bar, 100mm. (c) Depiction of aggregated expression patterns in
left BLA of strong cre-dependent mCherry expression at  1.8 DV in AAV-EF1a-DIO-rM3D(Gs)-mCherry infused animals. Scale bar, 100 mm. In all panels
error bars indicate mean±s.e.m.
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have high-quality drug interaction partners. These top curated
genes were then examined for expression patterns within the
BLA, using the Allen Brain Atlas or the literature.
Genes found to have increased expression in Thy1 neurons and
the BLA include: Dkk3, Tgfb, Rspo2, Nov, Dcn and Chrd; genes
found to have relatively decreased expression in Thy1 neurons and
the BLA include Ankfn1 and Pde7b (Fig. 5f–m). Data are shown
only from differentially regulated genes that had high-quality
coronal images in the Allen Brain Atlas30–37. Other genes that did
not have high-quality coronal in situ hybridization images available
through the Allen Institute were examined in the literature for
messenger RNA (mRNA) and protein expression. Several genes,
notably Ntsr2, were determined to have enriched or depleted
expression in BLA and thus met inclusion criteria38,39. RNA
sequencing expression data were validated using quantitative PCR
(qPCR) for select genes of interest. Follow-up qPCR supported a
strong upregulation of YFP, Thy1 and Ntsr2 mRNA in YFPþ
sample (Supplementary Fig. 4). Results from qPCR validation
performed on RNA used for sequencing replicate data
demonstrated that the ﬂuorescent Thy1 neurons were successfully
sorted, and that RNA sequencing indeed identiﬁed differentially
expressed genes that are selectively upregulated in these neurons.
This methodology strongly biases our results towards genes
that are selectively upregulated in Thy1 neurons to the exclusion
of genes with equal population-speciﬁcity, but less regional
speciﬁcity. Our goal is to discover putative drug targets selectively
acting on the ‘Fear-Off’ population within the BLA. This goal is
most efﬁciently achieved by narrow consideration of genes that
are highly upregulated in putative Fear-Off populations.
Protein expression patterns of six genes selectively upregulated
in Thy1-eYFP neurons were next examined using immunohis-
tochemistry in tissue from Thy1-eYFP mice (Fig. 6; Supple-
mentary Fig. 5). Using confocal microscopy, the degree of
co-localization between the protein of interest and Thy1-eYFP
neurons was examined quantitatively. Images were taken in
regions of high Thy1-eYFP density with equal numbers of
volumes analysed anteriorly and posteriorly. Genes examined are:
Ntsr2, Dkk3, TgfB2, Rspo2, Wnt 7a and Dcn. Across all markers
examined, none had 41% of YFP-positive cells that did not
co-localize with the marker of interest (Supplementary Fig. 6). All
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Figure 5 | Workﬂow describing FACS sorting and sequencing of RNA of Thy1-eYFP cell bodies, cell-type-speciﬁc RNA sequencing and identiﬁcation of
differentially regulated gene transcripts. (a) Schematic indicating location of tissue punch. The bilateral amygdala of Thy1-eYFP mice were obtained via
bilateral 1mm punches centred over the basolateral amygdala. These tissue samples were dissociated into single-cell suspensions, ﬁxed and stained for
neuronal marker, NeuN. Cell suspensions were sorted based on ﬂuorescent proﬁles and NeuNþ /YFP and NeuNþ /YFPþ populations were collected
for RNA analysis. (b) Representative scatterplot generated during FACS. Box P4 indicates NeuNþ /YFP events, Box P5 indicates NeuNþ /YFPþ events.
Inset: representative FSC/SSC; neuron cell bodies were present in small population at bottom. (c) Chart demonstrating total number of sequences yielded
with RNA-seq collected by each sample with FACS. (d) Image of YFP expression in Thy1-YFP mouse amygdala Scale bar, 100 mm. (e) 40 magniﬁcation of
Thy1-YFP expression demonstrating that only a subset of cell bodies (indicated by DAPI; blue) express YFP (Green) scale bar, 20 mm. (f–m) Examples of
genes identiﬁed as differentially regulated. RNA sequencing yielded a list of hundreds of differentially regulated genes. After reﬁnement using a
predetermined set of exclusion criteria (Supplementary Fig. 3) RNA expression patterns of genes were examined using the Allen Brain Map for enriched
expression within the BLA. Green arrows indicate genes up regulated in Thy1-eYFP neurons versus all other neurons (Dkk3, Tgfb, Rspo2, Nov, Dcn and Chrd).
Red arrows indicate genes down regulated in Thy1-eYFP neurons versus all other neurons (Ankfn1 and Pde7). Image Credit: Allen Institute31–37. Scale bar,
B100mm.
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genes exhibited staining in some cells that were not YFP positive,
suggesting that the Thy1-eYFP population may be marking a
majority sub-population of a larger population with a common
protein expression proﬁle.
To conﬁrm that these apply across Thy1 transgenic lines,
tissue previously used for the above chemogenetic experiments
was stained using antibodies against Dkk3 and TGFB2, and
co-localization was measured with Gs-DREADD expression.
A majority population of co-labelled cells was revealed with a
minority population of cells single labelled for the gene of
interest and B1% Thy1-Cre-marked neurons remaining
unlabelled. Although all markers had high levels of
co-localization in the regions analysed, Ntsr2 and Dkk3
displayed regional homology across all amygdala sections
examined (Supplementary Fig. 7). Furthermore, the availability
of high-quality agonist and antagonist drugs, acting speciﬁcally
at NTSR2 prompted the further investigation of NTSR2 and its
role in fear learning40,41.
Pharmacological manipulation of NTSR2. The above evidence
suggested that the NTSR2 is highly expressed within the Thy1
neurons within the BLA, sharing consistent regional and cellular
speciﬁcity (Fig. 7a). To assess NTSR2 as a target for actuating
pharmacological manipulation of fear behaviours, a selective
NTSR2 agonist, beta-lactotensin, was acquired and its effects on
fear expression measured. Mice were fear conditioned (Fig. 7b)
and 24-h later, 2 h before fear extinction, mice were injected
intraperitoneally (i.p.) with either saline or beta-lactotensin
(30mg kg 1)42. No within-session effect of beta-lactotensin on
fear expression was detected; however, during extinction
retention, 2 h after a second injection, a signiﬁcant decrease in
freezing was detected during the ﬁrst ten tone presentations in
mice receiving beta-lactotensin administration. These data
suggest that beta-lactotensin may act to enhance NTSR2
activity, stimulating the amygdala ‘Fear-Off’ population and
enhancing fear extinction consolidation and expression of
extinction.
TGFB2 Thy 1 YFP TGFB2 / Thy 1 YFP 
DKK3 Thy 1 YFP DKK3 / Thy 1 YFP
NTSR2 Thy 1 YFP NTSR2 / Thy 1 YFP
Thy 1 Cre - Gs DKK3 Thy 1 Cre – Gs / DKK3
Thy 1 Cre - Gs TGFB2 Thy 1 Cre – Gs / TGFB2
a
c
d
e
b
Figure 6 | Molecular characterization of basolateral amygdala Thy1 neurons. Examination of co-localization with protein products of identiﬁed
differentially expressed genes. Molecular characterization of Thy1-eYFP-expressing neurons of the basolateral amygdala was completed on tissue from
Thy1-eYFP line H mice. Coronal sections were stained for protein of interested using immunohistochemistry visualized using secondary antibodies emitting
in the red spectrum. Thy1-eYFP strongly co-localizes with (a) NTSR2, (b) DKK3 and (c) TGFB2. Tissue taken from Thy1-Cre-expressing animals infused
bilaterally with AAV-EF1a-DIO-rM3D(Gs)-mCherry allows visualization (red) of Thy1-Cre-expressing neurons. Coronal sections of this tissue was stained
above for (d) DKK3 and (e) TGFB2, revealing that these markers co-localize to similar extent with both Thy1-eYFP and Thy1-Cre. Scale bars, 20mm.
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Figure 7 | Modulating neurotensin receptor 2 activity alters fear expression and consolidation. (a) Regionally NTSR2 has an overlapping regional
expression pattern to Thy1-eYFP along the rostral-caudal axis of the amygdala. Scale bar, 200mm. (b) Beta-lactotensin, a NTSR2 agonist, was given i.p. at
2 h before fear extinction and fear extinction retention sessions. This enhanced consolidation of fear extinction as measured by signiﬁcantly decreased fear
expression during ﬁrst 10 CS presentations of fear extinction retention session (two-way RM ANOVA, F(1,19)¼ 5.39, *Po0.05). (c) Intra-amygdala infusion
of 90 mg per hemisphere beta-lactotensin 30min before fear extinction test yields near signiﬁcant decreases in within-session freezing expression (two-
way RM ANOVA, F(2,32)¼ 2.707, P¼0.085); however, infusion of 1.5mg per hemisphere levocabastine causes no within-session effects, but blunts fear
extinction consolidation as measured by increased freezing during fear extinction retention session (two-way RM ANOVA, F(2,20)¼6.633, Po0.01,
Dunnetts multiple comparison test versus control *Po0.05). (d) To ensure prior training did not cause previous results, and to test a lower dose of drug,
naive animals received bilateral infusion of 30 mg per hemisphere beta-lactotensin or saline control. Infusion of this lower dose of beta-lactotensin again
resulted in dramatic reductions in within-session freezing (two-way RM ANOVA, F(1,9)¼ 13.28, *Po0.01). In all panels error bars indicate mean±s.e.m.
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We next wished to conﬁrm that the behavioural effects
detected following peripheral administration of beta-lactotensin
reﬂect changes in activity of BLA NTSR2-expressing neurons.
Thus, we performed another experiment directly comparing
agonists and antagonists at this receptor with targeted intra-
amygdala injections. Beta-lactotensin and levocabastine, a
selective NTSR2 antagonist, were applied directly to the amygdala
in separate cohorts of mice before fear extinction (Fig. 7c). Mice
were cannulated bilaterally with cannulae aimed so that the
injector tip rested just above the BLA. On the basis of our halor-
hodopsin experiments, a weak fear conditioning (0.4mA US)
was necessary to avoid ceiling effects. Twenty-four hours
later mice were infused bilaterally into the BLA with beta-
lactotensin (90 mg per hemisphere), levocabastine (1.5mg per
hemisphere) or vehicle (5% dimethylsufoxide (DMSO) in saline,
needed to maintain common vehicle), 30min before fear
expression. Mice infused with beta-lactotensin had a strong, but
non-signiﬁcant trend towards reduced freezing throughout the
fear extinction session, suggesting that activating NTSR2 in the
BLA is sufﬁcient to decrease fear. There was no within-session
effect of levocabastine infusion during fear expression; however,
during the fear extinction retention session, mice that previously
had been infused with levocabastine froze signiﬁcantly more than
control. To conﬁrm that observed effects on freezing were not due
to changes in anxiety-like behaviour or locomotion, mice were
infused with their original drug and placed in an open-ﬁeld
chamber for 10min. No differences between groups were detected
in either time spent in centre or distance travelled
(Supplementary Fig. 8). Together, these data suggest that
inhibiting NTSR2 within the BLA is sufﬁcient to block fear
extinction resulting in more fear expression.
Although beta-lactotensin has high afﬁnity for NTSR2, it has
10-fold lower afﬁnity for NTSR1 as well. To conﬁrm that
observed behavioural changes were not due to off-target agonism
of the NTSR1 mice a separate, naive cohort of mice were
cannulated and fear conditioned at a higher shock intensity
(0.65mA; Fig. 7d)43. Mice were infused bilaterally with beta-
lactotensin at a threefold lower concentration (30 mg per
hemisphere) or sterile saline 30min before fear extinction
session. Mice that received infusion of beta-lactotensin
expressed signiﬁcantly less fear than their saline-infused
counterparts. Interestingly, during the pre-CS period the group
infused with beta-lactotensin showed less fear compared with
controls as well, suggesting that the agonism of the NTSR2 causes
generalized inhibition of fear expression (unpaired t-test,
Po0.01). Twenty-four hours later mice were subjected to
another fear extinction retention session without drug, and no
detectable differences were measured between groups, possibly
due to the previous full fear extinction test resulting in a ﬂoor
effect. Overall, these experiments show that activation of NTSR2
within the amygdala is sufﬁcient to decrease fear expression.
Examination of projection patterns of BLA Thy1-Cre neurons.
To understand how the Thy1/NTSR2 population ﬁts into a larger
fear-controlling circuitry, it is necessary to uncover the speciﬁc
projections of this population. Thy1-Cre-expressing mice were
infused unilaterally with cre-dependent (AAV-DIO-GFP) virus
into the BLA at different anterior to posterior positions ( 1.0,
 1.5,  2.0). After 3 months, animals were killed and the
patterns of ﬂuorescent protein expression were examined
descriptively throughout forebrain structures for regions of
apparent strong and weak YFP ﬂuorescence. Labelled cell bodies
were found primarily within 0.5mm along the A/P axis of the site
of infusion (Supplementary Figs 9f, 10e,f and 11c,d). Examination
of patterns made by ﬁlled terminals were made with no a priori
hypotheses and revealed strong projections from BLA Thy1
neurons to several regions, including nucleus accumbens (NAc)
core and shell, and bed nucleus of the stria terminalis (BNST;
Supplementary Figs 9b,c, 10a,c,g and 11b). Both of these regions
mediate, among many other functions, reward and positive
valence. Additional projections were found to the prefrontal
cortex (with some speciﬁcity for the Infralimbic cortex (IL)),
anterior insula, contralateral BLA and contralateral medial
intercalated nuclei (mITC)(Supplementary Figs 9a,d, 10b,d and
11a). These regions, especially IL and mITC have been strongly
implicated, as mediating extinction and fear suppression.
Importantly, although anterior infusions spare posterior cell
bodies and posterior infusions spare anterior cell bodies, few
discrepancies were found in the patterns of projections between
infusion sites. Importantly, and perhaps consistent with the
apparent role of the Thy1-marked cell in Fear-Off regulation,
there is little apparent projection to CeA from these labelled cells
(Supplementary Figs 9d,e, 10d–f and 11c).
When compared with cre-dependent tracing, biotinylated
dextran amine infused anteriorly into the BLA ( 1.5 A/P)
results in similar projection patterns; notably, projections are very
weak to the CeA as observed in Thy1-eYFP and Thy1-Cre
animals (Supplementary Fig. 12, CeA labelling in 12A is due to
over-ﬂow from infusion). Projections to IL and BNST are
observed as well. However when biotinylated dextran amine is
infused posteriorly ( 2.5 AP) there are strong projections
observed to all parts of the CeA, as well as BNST and anterior
insula (Supplementary Fig. 13). For additional discussion of
Thy1-Cre expression, see Supplementary Discussion (Supple-
mentary Figs 14 and 15). Taken together, these data suggest that
Thy1 ‘Fear-Off’ neurons conform to projection patterns of the
majority of rostral BLA neurons; however, they maintain their
segregated projections more caudally, where CeA projecting
neurons that likely have an alternative role in behaviour can be
found as well.
Discussion
Data presented here: (1) further identify and characterize a
functional role for the Thy1-marked amygdala neural population
in behaviour, (2) characterize the molecular proﬁle of this
population, (3) characterizes its circuit connectivity and (4) uses
that information to identify compounds that directly modulate
activity of the population in vivo. This represents an executable
methodology for behavioural and molecular characterization of a
neuron population leading to identiﬁcation of pharmacological
agents that act in vivo.
Four Thy1 transgenic lines mark consistent regional and
cellular populations speciﬁcally within the BLA. Populations
marked by these lines maintain consistent roles in learned fear
behaviour as indicated by their recruitment during fear extinction
(Thy1-eYFP), sufﬁciency of tonic enhancement of excitability for
augmented fear extinction consolidation (Thy1-Cre), and neces-
sity of activity for fear inhibition and extinction (Thy1-eNpHR).
Previously, we have demonstrated the Thy1-ChR2 line marks a
population whose activation is sufﬁcient to enhance fear
extinction (Jasnow et. al.15). Examination of differentially
regulated genes identiﬁed using FACS and RNA sequencing
reveals many genes that mark neuron populations that
consistently overlap with the Thy1-eYFP populations. Finally,
using drugs selectively targeting one identiﬁed marker, NTSR2,
yields behavioural results that consistently recapitulate those
observed with optogenetic and chemogenetic manipulations.
As is well known, use of the Thy1.2 expression cassette may
generate mice with drastically different transgene expression
patterns16. Similar expression patterns across mouse lines likely
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result from coincidental marking of a common developmental
population originating from the pallial zones of the
telencephalon17. Thus, we do not claim that Thy1 is a marker
of only the amygdala Fear-Off population, but rather that these
mouse lines conveniently mark a common developmental
population generating a population of neurons, including the
Fear-Off pyramidal neurons within the BLA in adulthood.
Additional consideration must be given to the fact that within
the Thy1-eNpHR mouse brain, populations in addition to the
BLA population examined are labelled, speciﬁcally hippocampal
and some cortical neurons. As there are many cell bodies and
processes labelled in the BLA, it impossible to determine whether
extrinsic terminals are also labelled, leaving the possibility
open that some effects may be due to inhibition of terminals or
ﬁbres of passage. Behavioural replication using virally induced
Gs-DREADD gives evidence that activity speciﬁcally of BLA Thy1
neurons is involved in fear learning; however, further study is
necessary.
Highly speciﬁc micro-iontophoresis of muscimol speciﬁcally
into the BLA blocks extinction consolidation without within-
session effects10. In our hands, selective inhibition of Thy1
neurons appears to allow maintenance of activity of the
previously silenced Fear-On circuitry. Thus, the fear circuit may
be artiﬁcially unbalanced, and we observe enhanced within-
session fear expression, in addition to previously observed deﬁcits
in extinction consolidation.
NTSR2, less studied than its high-afﬁnity partner NTSR1, is a
Gq-coupled signalling protein identiﬁed as a low-afﬁnity NTSR
with highly selective binding to levocabastine44. Recent reports
from Tye and colleagues have demonstrated differential roles in
behaviour for BLA neurons projecting to the CeA and NAc. The
high-afﬁnity NTSR1 may mark a CeA projecting population that
supports fear expression45. NTSR1 was not found to be
differentially regulated in Thy1-eYFP neurons in our study,
suggesting a dynamic and potentially complementary role for
neurotensinergic signalling in fear learning, perhaps dependent
upon differential projection patterns45. It is possible these
populations correspond to IL/PL projecting populations reported
by Senn et al.11; however, further study is needed11. Thus, we
propose that NTSR1 supports fear expression and NTSR2 supports
fear inhibition via their differential expression within the BLA.
Results demonstrating the fear suppressing effects of beta-
lactotensin are very encouraging; however, more research is
necessary to clearly deﬁne the mechanism by which this compound
is working. There have been reports of beta-lactotensin mediating
anti-nociception, anxiolysis and fear memory modulation42,46–48.
Although this is the ﬁrst report examining intra-amygdala
application of this compound in the context of auditory fear
conditioning, future studies will need to rigorously dissect the
mechanisms of this fear-suppression phenotype. Analysis of
projection patterns of BLA Thy1-Cre neurons reveals a strong
preference for regions commonly thought to be associated with
appetitive learning and fear suppression such as the NAc, medial
prefrontal cortex and mITC. Recently, there has been a great deal of
discussion concerning the implications of a heterogeneous BLA
population with distinct sets of neurons projecting to, for example,
the CeA or the NAc depending on whether they convey
information with negative or positive valence, respectively45. Here
we suggest that Thy1 labelled neurons, acting as proxy for NTSR2-
expressing neurons, correspond to the Fear-Off, and possibly
positive valence neurons, based upon their role in behavioural and
projection patterns.
Methods
Animals. Adult (8–12 week) B6.Cg-Tg(Thy1-eYFP)HJrs/J(Thy1-eYFP), B6.Cg-
Tg(Thy1-COP4/EYFP)18Gfng/J (Thy1-ChR2-EYFP), FVB/N-Tg(Thy1-Cre)1Vln/J
(Thy1-Cre), B6;SJL-Tg(Thy1-hop/EYFP)2Gfng/J (Thy1-eNpHR) and C57BL/6J
mice were obtained from Jackson Laboratories (Bar Harbor, ME, USA). All mice
were group housed and maintained on a 12:12 h light:dark cycle. Mice were housed
in a temperature-controlled colony and given unrestricted access to food and water.
All procedures performed conformed to National Institutes of Health guidelines
and were approved by Emory University Institutional Animal Care and use
Committee.
Surgical procedures. Mice were deeply anaesthetized with ketamine/dexdormitor
(medetomidine) mixture and heads ﬁxed into stereotaxic instrument (Kopf
Instruments). Stereotaxic coordinates were identiﬁed from Paxinos and Franklin
(2004) and heads were leveled using lambda and bregma. To allow for optical
inhibition (Fig. 3), mice were implanted unilaterally with an optical ﬁbre (length
5mm, 0.22 numerical aperture, 200 mm core; Thor labs) housed in a ceramic ferrule
(Thor Labs) just dorsal to the BLA ( 1.8mm AP, ±3.4mm ML,  4.8mm DV)
implants were randomized to side. Ferrules were adhered to the skull with adhesive,
then a protective head cap was constructed using dental cement. For viral delivery
(Fig. 4), a 10ml microsyringe (Hamilton) was lowered to coordinates just above
BLA and 0.5 ml of virus solution was infused at 0.1 ml min 1 using microsyringe
pump. Virus solution contained either puriﬁed AAV5-hSyn-DIO-rM3D(Gs)-
mCherry or AAV5-hSyn-eGFP in PBS (UNC Viral Vector Core). After infusion,
syringes rested at injection for 15min then slowly were withdrawn. After bilateral
infusion, incisions were sutured closed using nylon monoﬁlament (Ethicon). For
pharmacological experiments (Fig. 7), mice were implanted bilaterally with a guide
cannula (length 5mm, 22G, Plastics One) so that infuser tip rested just above the
BLA as before. Guide cannulae were attached to the skull with adhesive and a head
cap was constructed using dental cement. After dental cement cured dummy stilets
were placed into cannulae. For all surgeries, body temperature was maintained
using a heating pad. After completion of surgery, anaesthesia was reversed using
Antisedan (atipamezole) and mice were allowed to recover on heating pads.
Laser delivery. Optogenetic inhibition was achieved using a 50mW DPSS 593 nm
laser (Ikecool Inc., Anaheim, CA, USA). Laser-coupled ﬁbre was attached to an
optical ﬁbre patch chord via a rotary joint (Doric) and suspended above beha-
vioural testing chambers. Patch cords were attached directly to a chronically
implanted optic ﬁbre. Animals received 30 s of 10mW (79.55mWmm 2) tonic
light during ‘tone on’ epochs of cued fear behaviours. For open-ﬁeld experiments
mice received tonic light for alternating 2.5-min light-on but not light-off periods.
Drug administration. CNO (Sigma) was diluted in sterile saline and administered
at 1mg kg 1 i.p. beta-lactotensin (National Institute of Mental Health (NIMH))
used for i.p. experiments (Fig. 7c) was prepared in sterile saline and administered at
30mg kg 1 2 h before behavioural testing. Beta-lactotensin used for initial intra-
amygdala experiment (Fig. 7d) was prepared in 5% DMSO in sterile saline and
administered at 90 mg perhemisphere 30min before behavioural testing. Levoca-
bastine (Sigma; Fig. 7d) was prepared fresh before the administration in 5% DMSO
and administered at 1.5 mg per hemisphere. Beta-lactotensin used for follow-up
replication (Fig. 7e) was prepared in sterile saline and administered at 30 mg per
hemisphere 30min before behavioural testing.
Behavioural assays. Auditory cue-dependent fear conditioning. Mice were
habituated to fear-conditioning chambers (Med Associates Inc., St Albans, VT) for
10min each of 2 days before fear conditioning. Mice were conditioned to ﬁve tones
(10 for Thy1-Cre experiment, Fig. 4; 30 s, 6 kHz, 65–70 db) co-terminating with a
foot shock (1 s 0.4mA(weak), or 0.65mA(regular) depending on session).
Auditory cue-dependent fear expression and extinction. Cue-dependent fear
extinction was tested 24 h after fear conditioning and extinction retention occurred
24 h after fear expression. For extinction, mice were placed in a novel context and
exposed to 15 or 30, 30 s tones with an inter trial interval of 60 s. Freezing was
measured using Freeze View software (Coulbourn Instruments Inc., Whitehall, PA,
USA) or hand scored by two blinded experimenters (Fig. 3).
Behavioural tests for c-fos expression experiments. As above, animals were
habituated to training chamber. As above, animals were fear conditioned to
5 CS/US pairings. For fear extinction, mice were extinguished to 30 CS tones in an
alternate context. The next day for fear extinction retention testing, mice were
re-exposed to a single CS in the extinction context. Mice were killed as below
90min following cessation of behaviour.
Open ﬁeld. Open-ﬁeld chambers (Med Associates) were placed in a dimly lit
room. Mice were placed in the chamber for 10min and allowed to explore. For
optogenetic experiments mice received light during the second and ﬁnal 2.5min of
the session.
Dissociation of amygdala tissue for FACS. For each of three replicates where
RNA was collected from isolated neurons three groups of three Thy1-eYFP
mice and several control C57 mice were rapidly decapitated and bilateral 1mm
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amygdala punches were taken within 2min. To minimize RNA degradation each
solution used was prepared with RNAse Out (Life Technologies Inc., Bedford, MA,
USA) and kept on ice. Each pair of amygdala punches was homogenized with a
razorblade on a cold glass Petri dish then transferred to cold Hibernate A
(Life Technologies). Tissue was spun down and supernatant replaced with 1ml
Accutase (Innovative Cell Technologies, Inc., San Diego, CA, USA) and allowed to
digest for 30min while rotating at 4 C. Digested tissue was spun down and
resuspended in cold Hibernate A. Three sets of punches were combined (for a total
of N¼ 3 mice per sample) and tissue was manually dissociated by trituration using
ﬁre polished Pasteur pipettes with diameters 1.3, 0.8 and 0.4mm in series, where
supernatant was collected and volume restored between each step. Cell suspensions
were spun down and cell pellet resuspended in Hibernate A. Cell suspensions were
ﬁltered through pre-wetted 100 and 40 mm ﬁlters (BD Biosciences, Inc., San Jose,
CA, USA) in series.
Immunolabeling cell suspension for FACS. Cells were ﬁxed by adding equal
volumes of 100% ice cold EtOH and incubating for 15min. Fixed cells were spun
down and resuspended in sterile PBS. After removing appropriate aliquots for
gating and compensation controls ﬁxed cells were incubated with biotinylated anti-
NeuN antibody (1:1,000, Milipore) and Hoechst (1:1,000, Sigma) while rotating at
4 C. Cells were pelleted and washed with PBS. Cell suspensions were incubated
with secondary allophycocyanin-labelled streptavidin (1:1,000, Invitrogen) for
30min while rotating at 4 C. Cells were pelleted and washed twice with cold PBS.
Flow cytometry. A FACS Aria II (BD Biosciences) was used for cell sorting
(Flow Cytometry Core at Yerkes National Primate Center). A portion of cells
collected from wild-type mice was used to gate based on forward scatter (FSC) and
side scatter (SSC) light scattering, and Hoechst ﬂuorescence characteristics.
Another portion of wild-type cells incubated exclusively in secondary antibody was
used to set threshold for nonspeciﬁc binding of allophycocyanin–streptavadin
binding and auto ﬂuorescence in the 488 nm channel. Finally, stained cells collected
from Thy1-eYFP mice were sorted and samples collected. For initial character-
ization, samples were collected in PBS and samples examined under ﬂuorescent
microscope to verify correct sorting. Thereafter, cells were sorted directly into lysis
media of RNeasy Micro Kit (Qiagen) and kept at 4 C. After sorting was completed
RNA was isolated according to manufacturer’s instructions including on-column
DNase treatment. Samples were combined into single tube, and RNA quantity and
quality were determined using Bioanalyzer pico chip (Agilent).
Real-time PCR. RNA was reverse transcribed and ampliﬁed using SMARTer HV
kit (Clonetech). Quantitative PCR was performed on complementary DNA with
each sample run in triplicate technical replicates. Reactions contained 12 ml
Taqman Gene Expression Master Mix (Applied Biosystems), 1 ml of each forward
and reverse primer, 1 ml of 5 ng ml 1 complementary DNA and 6 ml water.
Primers were proprietary ﬂuorescein amidite (FAM)-labelled probes from Life
Technologies. Quantiﬁcation of qPCR was performed on Applied Biosystems
7500 Real-Time PCR System. Cycling parameters were 10min at 95 C, 40 cycles of
ampliﬁcation of 15 s at 95 C and 60 at 60 C, and a dissociation step of 15 s 95 C,
60 s at 60 C, 15 s 95 C. Fold changes of YFPþ over YFP groups were calcu-
lated as DDCT values normalized to levels of actin B mRNA. Values presented as
fold change ±s.e.m.
Immunohistochemistry. For visualization of Decorin and RSPO2, Thy1-eYFP
mice were perfused and brains were post ﬁxed for 2 h using Zamboni Fixative. For
all other visualizations mice were perfused and brains were post ﬁxed for 2 h with
4% paraformaldehyde. Free-ﬂoating brain sections (35 mm) were rinsed in PBS,
then in blocking solution (PBS, 10% normal goat serum, 0.25% Tween-20 and 0.4%
Triton-X 100) for 1 h at room temperature and incubated for 24 h at 4 C with the
following antibodies in PBST: DKK3 (1:200, Abcam), TGFB2 (1:5,000, Abcam),
Wnt7a(1:5,000, Santa Cruz), RSPO2 (1:200, Abcam), NTR2 (1:500, Santa Cruz)
and Decorin (1:1,000, Santa Cruz). Sections stained for NTR2 underwent an
ampliﬁcation process, which consisted of a PBS rinse, 30min incubation in
peroxidase-labelled goat anti-rabbit (1:1,000, Vector Labs) at room temperature,
another PBS rinse and 10min in Fluorophore Tyramide Working Solution
(TSA Plus Cyanine3 System)
All other sections were rinsed in PBS and incubated for 2 h at room temperature
with either Alexa-Fluor 568 donkey anti-goat (1:1,000, Invitrogen) or Alexa-Fluor
594 goat anti-rabbit (1:1,000, Invitrogen) depending on the primary antibody’s
host. Following another PBS rinse, sections were mounted, then stained with
Hoechst (1:1,000, Sigma) before being given a ﬁnal PB rinse and cover-slipped with
Mowiol mounting medium.
RNA-seq library preparation. Libraries were generated from 1 ng of total RNA
using the SMARTer HV kit (Clonetech), barcoding and sequencing primers were
added using NexteraXT DNA kit. Libraries were validated by microelectrophoresis,
quantiﬁed, pooled and clustered on Illumina TruSeq v3 ﬂowcell. Clustered ﬂowcell
was sequenced on an Illumina HiSeq 1,000 in 100-base single-read reactions.
Analysis of RNA sequencing data. RNA sequencing data was analysed using
Tuxedo DESeq analysis software. Differential expression between YFPþ and
YFP groups were obtained and used for further analysis. Using the q value of
o0.05 as a cutoff, only highly signiﬁcant returns were used for further analysis. To
ensure that genes had a large enough difference in expression to warrant phar-
macological manipulation, only those with differences in expression greater than
20.5 or B141% were considered. Next using the ‘Drug Gene Interaction Database’
returns were examined for having a known pharmacological agent that modiﬁes its
activity. Genes lacking viable pharmacological modulators were eliminated.
Statistics. Statistical analyses were performed using Prism 6 by Graph Pad. All
data presented as mean±s.e.m. Differential c-fos expression was examined using a
two-way ANOVA with behavioural condition as the between-subjects factor and
Sidak’s multiple comparisons test versus Home Cage. For comparison of eight c-fos
expression groups, two-way ANOVA was performed followed by Sidak’s post hoc
multiple comparisons test. All behavioural experiments were examined using a
repeated measures ANOVA with drug or optogenetic stimulation as the between-
subjects factor and tone presentation as the within subject factor. Open-ﬁeld
activity (time in centre and distance travelled) was compared using a Student’s
t-test between carrier and non-carrier groups. For qPCR, DDCT values of data were
compared by Student’s t-test between YFPþ and YFP groups. For all tests
statistical signiﬁcance was set at Po0.05.
Analysis of BLA Thy1-Cre projections. Three months post-viral infusion animals
were killed and tissue was prepared as above. Slices were initially examined to
conﬁrm that cell bodies were labelled primarily in the BLA and that sight of
expression conformed with target area. Slices were examined broadly with no a
priori hypotheses about projection patterns. Images were taken using consistent
exposure times within subject to preserve consistency of brightness of staining.
Images at lower exposure time were taken of BLA for publication purposes to avoid
over-exposure of YFP expressing cell bodies. Areas were characterized broadly as
having either strong or weak ﬂuorescent expression. From areas found to have
strong expression, those known to play a role in fear learning and expression are
highlighted in text.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon request
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